2023
DOI: 10.1002/jso.27392
|View full text |Cite
|
Sign up to set email alerts
|

Surgical treatment of stage IV gastroenteropancreatic neuroendocrine carcinoma: Experience and outcomes in the United States

Abstract: Background and ObjectivesSurgery for metastatic gastroenteropancreatic neuroendocrine carcinoma (GEP‐NEC) has not been well‐studied. This retrospective cohort study describes patients in the United States with stage IV GEP‐NEC and their survival outcomes segregated by surgery.MethodsPatients diagnosed with stage IV GEP‐NEC from 2004 to 2017 in the National Cancer Database were categorized into three groups: no surgery, primary site or metastatic site (“single‐site”) surgery, and primary site and metastatic sit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 41 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?